Phibro Animal Health has filed for an IPO. The number of shares that will be offered and its pricing terms have not yet been set. The stock will trade on the NASDAQ under the ticker symbol “PAHC.” BofA Merrill Lynch, Morgan Stanley & Co. and Barclays Capital are the lead underwriters. Based in Teaneck, NJ Phibro is a maker of animal health and mineral nutrition products. Its backers include 3i Group.
Teaneck, New Jersey, March 10, 2014 – Phibro Animal Health Corporation (“Phibro” or “the Company”) announced today that it has publicly filed a registration statement on Form S-1 with the Securities and Exchange Commission (the “Commission”) relating to a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. The common stock is expected to be listed on The NASDAQ Stock Market under the symbol “PAHC.” The Bendheim family is not selling any shares in the offering and will remain in control of the Company following the offering. The Company’s minority stockholder, Mayflower Limited Partnership, managed by 3i Investments plc, will be a selling stockholder in the offering, and newly issued shares will also be sold by the Company, which intends to use the net proceeds from the offering to repay certain of its outstanding debt, pay related fees and expenses and for general corporate purposes.
BofA Merrill Lynch, Morgan Stanley & Co. LLC and Barclays Capital Inc. are serving as joint book-running managers for the proposed offering.
The proposed offering will be made only by means of a prospectus. A copy of the preliminary prospectus related to the offering, when available, may be obtained from BofA Merrill Lynch, Attn: Prospectus Department, 222 Broadway, New York, New York 10038, or by email: firstname.lastname@example.org, Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, via telephone: +1 (866) 718-1649 or by email: email@example.com and Barclays Capital Inc. (c/o Broadridge Financial Solutions) 1155 Long Island Avenue, Edgewood, New York 11717, via telephone: +1 (888).603-5847 or by email: Barclaysprospectus@broadridge.com.
The registration statement on Form S-1 relating to these securities has been filed with the Commission but has not yet become effective. These securities may not be sold nor may offers to buy these securities be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture.